Literature DB >> 6648517

L-tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria?

D A Litman, M A Correia.   

Abstract

Hepatic porphyrias are disorders of heme synthesis characterized by genetically determined lesions of one of the key enzymes of heme synthesis. In carriers of such lesions, several factors (drugs, environmental chemicals, or diet) precipitate acute and often fatal attacks of neurologic dysfunction, which are promptly relieved by intravenous infusion of heme. However, the mechanism of such heme-induced amelioration remains elusive. To probe this mechanism, the biochemical events triggered by acute hepatic heme deficiency were examined in an animal model of chemically induced porphyria. Acute hepatic heme depletion in porphyric rats was found to impair hepatic tryptophan pyrrolase activity which, in turn, elevated tryptophan and 5-hydroxytryptamine turnover in the brain. These alterations in porphyric rats were dramatically reversed by parenteral heme administration. These findings suggest that increased tryptophan and 5-hydroxytryptamine in the nervous system may be responsible for the neurologic dysfunctions observed in humans with acute attacks of hepatic porphyria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6648517     DOI: 10.1126/science.6648517

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  13 in total

1.  Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.

Authors:  Nicholas J Heyer; Diana Echeverria; James S Woods
Journal:  Autism Res       Date:  2012-02-01       Impact factor: 5.216

2.  Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases.

Authors:  A S Winkler; T J Peters; R D C Elwes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

3.  Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria.

Authors:  R L Lindberg; R Martini; M Baumgartner; B Erne; J Borg; J Zielasek; K Ricker; A Steck; K V Toyka; U A Meyer
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 4.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

Review 5.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

6.  Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children.

Authors:  James S Woods; Nicholas J Heyer; Diana Echeverria; Joan E Russo; Michael D Martin; Mario F Bernardo; Henrique S Luis; Lurdes Vaz; Federico M Farin
Journal:  Neurotoxicol Teratol       Date:  2012-07-02       Impact factor: 3.763

7.  Incorporation of haemoglobin haem into the rat hepatic haemoproteins tryptophan pyrrolase and cytochrome P-450.

Authors:  J F Wyman; J L Gollan; W Settle; G C Farrell; M A Correia
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

8.  In vitro distribution of porphyrin metabolites from 10(-3) M delta-aminolevulinic acid in primary neural tissue cultures.

Authors:  I Durkó; A Juhász
Journal:  Neurochem Res       Date:  1987-05       Impact factor: 3.996

9.  Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat.

Authors:  H Puy; J C Deybach; A Bogdan; J Callebert; M Baumgartner; P Voisin; Y Nordmann; Y Touitou
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

10.  Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: summary findings from the Casa Pia Children's Amalgam clinical trial.

Authors:  James S Woods; Nicholas J Heyer; Joan E Russo; Michael D Martin; Federico M Farin
Journal:  Neurotoxicology       Date:  2014-08-07       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.